To investigate the cell cycle regulatory mechanisms involved in the growth
of smooth muscle tumors, we studied the expression of Ki-67, cyclins E and
A, and their catalytic partners, the cyclin-dependent kinases cdk2 and cdc2
by using tissue specimens from benign and malignant smooth muscle tumors.
These included 20 cases of usual leiomyoma (UL), 18 of cellular leiomyoma (
CL), 8 of bizarre leiomyoma (BL), 8 of uncertain malignant potential tumors
(UMP) and 20 of leiomyosarcoma (LMS). The proliferation rare detected by K
i-67 was low in normal myometrium and leiomyomas (UL, CL and BL), but it wa
s markedly increased in LMS, The expression of the cyclins (E and A) and cd
ks (cdk2 and cdc2) was also low in normal myometrium and leiomyomas, Howeve
r, the expression; of these factors was markedly increased in LMS, In addit
ion, a survival analysis using Log-rank test, revealed that LMSs with posit
ive staining for cyclin A and with diffusely staining for cyclin E were ass
ociated with significantly shorter survival, Our results suggest that expre
ssion of cyclins and cdks may be involved in the growth control of uterine
smooth muscle tumors. Int. J. Cancer (Pred, Oncol) 84:244-250, 1999, (C) 19
99 Wiley-Liss, Inc.